PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30866987-6	2019	Notably, the reduced ceramide synthase 2 (Cers2), UDP glycosyltransferase 8 (Ugt8), and glycolipid transfer protein (Gltp) indicate the altered sphingolipid metabolism in the disease and the involvement of Gltp in myelination.	Sphingolipids	144-156	ceramide synthase 2	Mus musculus	21-40	
30866987-6	2019	Notably, the reduced ceramide synthase 2 (Cers2), UDP glycosyltransferase 8 (Ugt8), and glycolipid transfer protein (Gltp) indicate the altered sphingolipid metabolism in the disease and the involvement of Gltp in myelination.	Sphingolipids	144-156	ceramide synthase 2	Mus musculus	42-47	
27591968-4	2016	These strain-specific changes in sphingolipid acylation closely correlated with ceramide synthase 2 (CerS2) protein content and activity, with reduced CerS2 levels/activity observed in glucose intolerant strains and increased content in BALB/c mice.	Sphingolipids	33-45	ceramide synthase 2	Mus musculus	80-99	
27591968-4	2016	These strain-specific changes in sphingolipid acylation closely correlated with ceramide synthase 2 (CerS2) protein content and activity, with reduced CerS2 levels/activity observed in glucose intolerant strains and increased content in BALB/c mice.	Sphingolipids	33-45	ceramide synthase 2	Mus musculus	101-106	
25720061-5	2015	Both sphingolipids are crucially involved in the high susceptibility to infection of cystic fibrosis and CerS2-deficient mice, as indicated by findings showing that the normalization of ceramide and sphingosine levels rescue these mice from acute infection with P. aeruginosa.	Sphingolipids	5-18	ceramide synthase 2	Mus musculus	105-110	
25241943-1	2014	Ceramide synthase 2 (CerS2) null mice cannot synthesize very-long acyl chain (C22-C24) ceramides resulting in significant alterations in the acyl chain composition of sphingolipids.	Sphingolipids	167-180	ceramide synthase 2	Mus musculus	0-19	
25241943-1	2014	Ceramide synthase 2 (CerS2) null mice cannot synthesize very-long acyl chain (C22-C24) ceramides resulting in significant alterations in the acyl chain composition of sphingolipids.	Sphingolipids	167-180	ceramide synthase 2	Mus musculus	21-26	
22911490-7	2013	Moreover, DRMs in CerS2 null mice displayed properties significantly different from those in wild-type mice, suggesting that the altered sphingolipid acyl chain length directly affects insulin receptor translocation and subsequent signaling.	Sphingolipids	137-149	ceramide synthase 2	Mus musculus	18-23	
23690971-5	2013	Despite relatively preserved total lung ceramide levels, inhibition of de novo sphingolipid synthesis at the level of CerS2 was associated with significant airflow obstruction, airway inflammation, and increased lung volumes.	Sphingolipids	79-91	ceramide synthase 2	Mus musculus	118-123	
23283968-4	2013	Significant changes were observed in the sphingolipid profile of CerS2 null mouse liver, including elevated C16-ceramide and sphinganine levels in liver and in isolated mitochondrial fractions.	Sphingolipids	41-53	ceramide synthase 2	Mus musculus	65-70	
20110363-3	2010	We have generated a CerS2 null mouse and characterized the changes in the long chain base and sphingolipid composition of livers from these mice.	Sphingolipids	94-106	ceramide synthase 2	Mus musculus	20-25	
20110363-4	2010	Ceramide and downstream sphingolipids were devoid of very long (C22-C24) acyl chains, consistent with the substrate specificity of CerS2 toward acyl-CoAs.	Sphingolipids	24-37	ceramide synthase 2	Mus musculus	131-136	
17901973-12	2008	These data suggest that CerS2 is important for the synthesis of dihydroceramide used for synthesis of myelin sphingolipids.	Sphingolipids	109-122	ceramide synthase 2	Mus musculus	24-29